In vitro toxicity determination of antifungal constituents from Combretum zeyheri

Abstract

BackgroundCandida albicans is one of the organisms living on the human body symbiotically, but, in hosts with low immunity it becomes one of the most pathogenic fungal organisms. Combretum zeyheri has been reported to have antifungal, antibacterial and antioxidant activities. Medicinal plants are believed to be non-toxic by the general public. Toxicity studies, however, have indicated that they are capable of causing numerous side effects, therefore, evaluation of safety is required. The objective of this study was to determine the toxicity of the antifungal constituents of Combretum zeyheri on mammalian cells.MethodsAlkaloids, saponins, flavonoids-enriched extracts and crude ethanol extracts were prepared from the leaves of Combretum zeyheri. The broth microdilution method was used to investigate for antifungal activity, with miconazole used as the positive control. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay was used to determine cell viability of the Candida albicans cells. The most potent extracts; the ethanol extract, alkaloids and saponins respectively, were further tested for their toxicity on sheep erythrocytes, mouse peritoneal macrophages and Jurkat T cells.ResultsAll Combretum zeyheri extracts displayed a dose-dependent antifungal activity and had IC50 values ranging from 16 μg/ml to 159 μg/ml for Candida albicans. The alkaloids, saponins and ethanol extracts were found to be non-toxic towards mouse peritoneal cells and Jurkat T cells. In the haemolysis assay, all extracts were haemolytic at varying degrees and showed their greatest haemolytic activity at the highest concentration of 5 mg/ml. The saponins were the least haemolytic, followed by the ethanol extracts and the alkaloids respectively. Although these extracts were haemolytic to some extent, they may considered safe at therapeutic concentrations since there was a large difference between the antifungal IC50 and haemolysis EC50 values, hence a large therapeutic window.ConclusionsCombretum zeyheri antifungal constituents are, therefore, a potential source of lead compounds which can be developed into antifungal drugs of natural origin owing to Combretum zeyheri’s effective antifungal activity and low toxicity to mammalian cells.

Untitled

“…This observation may be attributed to the molecules on the cell surface of RBCs which may be directly or indirectly involved in the alteration in the functioning of the ion channels or other mechanisms involved in maintaining the osmotic balance. Similar results were observed when RBCs were exposed to extract of Ricinus communis L., where the extract proved to be toxic to cells and modified the cell membrane structure 7 and exposure to extract of Combretum zeyheri caused hemolysis in sheep erythrocytes 8 .…”

Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial

“…In addition, the osmolarity of sucrose causes the absorption of water and subsequently the disappearance of pathogenic bacteria [ 17 ]. As is warranted by the complications associated with chemical drugs [ 18 ], considering widespread use of traditional medications [ 19 ], the need for alternative treatment with fewer side effects, and the high prevalence of this infection among women, this study was conducted to compare the effects of sucrose gel with metronidazole gel in the treatment of women with bacterial vaginosis.…”

Antifungal potential of punicalagin against Cryptococcus neoformans species complex

“…Lysis of sheep erythrocytes cells is easily obtained by measuring the release of hemoglobin, constituting a good tool for toxicity studies. Determination of hemolysis activity is quick, reproducible, and inexpensive 28 .…”